# 外周静脉导管市场 > 外周静脉导管市场研究报告按产品类型（标准外周静脉导管、安全外周静脉导管、植入式外周静脉导管）、按材料（聚氨酯、特氟龙、聚乙烯）、按应用（静脉治疗、输血、药物给药）、按针规（16G、18G、20G）、按最终用户（医院、诊所、门诊手术中心）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.59% - **2024:** $ 9.62 Billion - **2025:** $ 10.16 Billion - **2035:** $ 17.5 Billion - **Key Players:** Becton Dickinson and Company (US), Smiths Medical (US), Terumo Corporation (JP), Medtronic plc (IE), Vygon S.A. (FR), Nipro Corporation (JP), Fresenius Kabi AG (DE), AngioDynamics, Inc. (US), Cardinal Health, Inc. (US) **Report ID:** MRFR/HC/28437-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/peripheral-intravenous-catheter-market-30180 --- ## Market Summary ## **Peripheral Intravenous Catheter Market Overview** As per MRFR analysis, the Peripheral Intravenous Catheter Market Size was estimated at 9.14 (USD Billion) in 2023. The Peripheral Intravenous Catheter Market Industry is expected to grow from 9.62 (USD Billion) in 2024 to 14.86 (USD Billion) by 2032. The Peripheral Intravenous Catheter Market CAGR (growth rate) is expected to be around 5.59% during the forecast period (2024 - 2032). ### **Key Peripheral Intravenous Catheter Market Trends Highlighted** Key market drivers for peripheral intravenous catheters include the increasing prevalence of chronic diseases, the growing adoption of minimally invasive surgeries, and technological advancements in catheter designs. Opportunities for market expansion lie in developing advanced catheters with enhanced safety features, antimicrobial coatings, and extended dwell times, as well as catering to the growing demand in emerging economies. Recent trends in the market have witnessed a shift towards safety-engineered catheters, needleless connectors, and smart infusion systems. The market is also driven by the need for effective and convenient fluid delivery systems, leading to the adoption of peripherally inserted central catheters (PICCs) and midline catheters. These trends suggest a growing demand for specialized and innovative peripheral intravenous catheters that meet the evolving needs of healthcare professionals and patients. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Intravenous Catheter Market Drivers** ### Increasing Prevalence of Chronic Diseases and Invasive Medical Procedures The rising incidence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, has led to an increased demand for peripheral intravenous catheters. These diseases often require long-term treatment and frequent administration of medications and fluids, which necessitates the use of reliable and efficient intravenous access devices. Additionally, the growing number of invasive medical procedures, including surgeries, biopsies, and diagnostic tests, has further contributed to the demand for peripheral intravenous catheters as they provide a safe and convenient means of administering fluids, medications, and other therapeutic agents. ### Technological Advancements and Product Innovations The Global Peripheral Intravenous Catheter Market Industry has witnessed significant technological advancements in recent years. Manufacturers are continuously investing in research and development to enhance the performance and safety of peripheral intravenous catheters. These advancements include the development of catheters with smaller diameters, improved materials, and enhanced safety features. For instance, the introduction of catheters with antimicrobial coatings has reduced the risk of infections and improved patient outcomes.Furthermore, the development of needle-free and self-inserting catheters has enhanced patient comfort and ease of use. ### Growing Focus on Patient Safety and Home Healthcare The increasing emphasis on patient safety and the shift towards home healthcare has also driven the growth of the Global Peripheral Intravenous Catheter Market Industry. Peripheral intravenous catheters offer a safe and convenient method of administering medications and fluids in both hospital and home settings. The growing preference for home healthcare, particularly for chronic disease management and post-operative care, has led to an increased demand for peripheral intravenous catheters that are easy to use, reliable, and minimize the risk of complications. ## **Peripheral Intravenous Catheter Market Segment Insights** ### **Peripheral Intravenous Catheter Market Product Type Insights** The Global Peripheral Intravenous Catheter Market segmentation by product type includes standard peripheral intravenous catheters, safety peripheral intravenous catheters, and implantable peripheral intravenous catheters. Standard peripheral intravenous catheters are the most common type, used for short-term intravenous therapy. Safety peripheral intravenous catheters have a safety mechanism to reduce the risk of needlestick injuries. The growth of the market can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in catheter design.Standard peripheral intravenous catheters dominate the market, accounting for the largest revenue share due to their widespread use in hospitals, clinics, and ambulatory surgical centers. Safety peripheral intravenous catheters are gaining popularity owing to their ability to prevent needlestick injuries, which is a major concern among healthcare professionals. Implantable peripheral intravenous catheters are expected to experience steady growth due to their advantages in long-term intravenous therapy. The Global Peripheral Intravenous Catheter Market is highly competitive, with numerous global and regional players.Key industry participants are focused on developing innovative products and expanding their geographic reach to cater to the growing demand for peripheral intravenous catheters. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Peripheral Intravenous Catheter Market Material Insights** The Material segment of the Global Peripheral Intravenous Catheter Market is segmented into Polyurethane, Teflon, and Polyethylene. Polyurethane dominates the market, capturing over 55% of the revenue in 2023. Its high strength, flexibility, and biocompatibility make it suitable for various applications. Teflon is expected to grow at a CAGR of 4.2% during 2024-2032 due to its inert properties and resistance to chemical reactions. Polyethylene, with a market share of around 20%, offers cost-effectiveness and is commonly used in short-term IV applications. ### **Peripheral Intravenous Catheter Market Application Insights** The Global Peripheral Intravenous Catheter Market is segmented based on application into intravenous therapy, blood transfusion, and drug administration. Among these, intravenous therapy held the largest market share in 2023, accounting for over 60% of the global market revenue. This is primarily attributed to the increasing prevalence of chronic diseases, such as cancer and diabetes, which require long-term intravenous therapy. The blood transfusion segment is also expected to witness significant growth over the forecast period, owing to the rising demand for blood transfusions in emergency situations and surgeries.The drug administration segment is anticipated to grow at a steady pace, driven by the increasing adoption of peripheral intravenous catheters for the administration of various drugs, including antibiotics, pain relievers, and chemotherapy drugs. ### **Peripheral Intravenous Catheter Market Needle Gauge Insights** The Needle Gauge segment is a crucial aspect of the Global Peripheral Intravenous Catheter Market, influencing market growth and segmentation. In 2024, the 16G segment held a significant market share, accounting for approximately 32% of the overall market revenue. This dominance is attributed to its versatility and widespread use in various clinical settings, including emergency and critical care units. The 18G segment follows closely, capturing around 28% of the market revenue in 2024. Its popularity stems from its suitability for administering fluids, medications, and blood transfusions. Meanwhile, the 20G segment is projected to exhibit steady growth, reaching a market share of approximately 22% by 2032. This segment caters to specific applications such as pediatric and geriatric care, where smaller gauge catheters are preferred for patient comfort and reduced risk of complications. The market data suggests that the Needle Gauge segment will continue to drive industry growth, with increasing demand for minimally invasive and effective [intravenous therapy](../../../reports/intravenous-therapy-vein-acces-market-32528) solutions. ### **Peripheral Intravenous Catheter Market End User Insights** The end-user segment of the Global Peripheral Intravenous Catheter Market is categorized into hospitals, clinics, and ambulatory surgical centers. Hospitals are expected to hold the largest market share due to the high volume of patients requiring intravenous therapy and the presence of advanced medical infrastructure. In 2023, the hospital segment is estimated to account for around 60% of the Global Peripheral Intravenous Catheter Market revenue. Clinics are projected to witness significant growth due to the increasing number of outpatient procedures and the convenience they offer to patients.Ambulatory surgical centers are anticipated to contribute a notable share of the market, driven by the growing demand for same-day surgeries. ### **Peripheral Intravenous Catheter Market Regional Insights** The regional segmentation of the Global Peripheral Intravenous Catheter Market offers valuable insights into the market's growth dynamics and competitive landscape. 'North America' is projected to account for a significant share of the Global Peripheral Intravenous Catheter Market revenue, driven by the presence of major market players, advanced healthcare infrastructure, and a high prevalence of chronic diseases. 'Europe' follows closely behind, with a robust healthcare system and a growing elderly population. 'APAC' is expected to witness substantial growth in the coming years, fueled by rising healthcare expenditure and increasing awareness about modern medical technologies.South America' and 'MEA' are also expected to contribute to the overall market growth, albeit at a slower pace. The Global Peripheral Intravenous Catheter Market is highly competitive, with key players focusing on product innovation, strategic partnerships, and geographical expansion to gain market share. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Peripheral Intravenous Catheter Market Key Players And Competitive Insights** Major players in the Peripheral Intravenous Catheter Market industry are focusing on product development and innovation to gain a competitive edge in the market. Leading Peripheral Intravenous Catheter Market players are investing heavily in research and development to introduce advanced products with improved features and functionalities. The Peripheral Intravenous Catheter Market is characterized by the presence of intense competition among the top players. These players are continuously striving to gain market share by adopting various strategies such as product innovation, partnerships, and acquisitions. The Peripheral Intravenous Catheter Market Competitive Landscape is expected to remain highly competitive in the coming years. Key players are likely to focus on expanding their product portfolios, increasing their geographic presence, and enhancing their distribution networks to cater to the growing demand for peripheral intravenous catheters.BD is a leading global medical technology company that provides a wide range of products and services to the healthcare industry. The company's Peripheral Intravenous Catheter portfolio includes a variety of products designed to meet the needs of different patients and clinical settings. BD's Peripheral Intravenous Catheters are known for their high quality, reliability, and ease of use. The company has a strong distribution network and a global presence, which allows it to reach a wide range of customers. BD is committed to providing innovative and cost-effective solutions to meet the evolving needs of the healthcare industry.3M is a leading provider of healthcare products and services. The company's Peripheral Intravenous Catheter portfolio includes a wide range of products designed for various applications. 3M's Peripheral Intravenous Catheters are known for their safety, effectiveness, and reliability. The company has a strong research and development program, which allows it to develop and introduce new products to meet the evolving needs of the healthcare industry. 3M has a global presence and a strong distribution network, which allows it to reach a wide range of customers. The company is committed to providing innovative and cost-effective solutions to improve patient outcomes and reduce healthcare costs. ### **Key Companies in the Peripheral Intravenous Catheter Market Include** - Vygon - Merit Medical Systems, Inc. - Becton, Dickinson and Company - Convatec Group plc - **[Cardinal Health](https://shop.cardinalhealth.ca/chc/insyte-peripheral-venous-catheter)** - Terumo Corporation - Argon Medical Devices, Inc. - Smiths Medical - Baxter International Inc. - Smith Nephew - Braun Melsungen AG - BD (Becton, Dickinson and Company) - Asahi Intecc Co., Ltd. - Medtronic plc - Teleflex Incorporated ## Peripheral Intravenous Catheter Market Industry Developments - **Q2 2024: B. Braun Launches Introcan Safety® 2 IV Catheter in the U.S.** B. Braun Medical Inc. announced the U.S. launch of the Introcan Safety® 2 IV Catheter, designed to reduce needlestick injuries and improve patient safety, expanding its peripheral intravenous catheter portfolio. - **Q2 2024: Smiths Medical Announces FDA Clearance for Jelco Hypodermic Needle-Pro Edge Safety Device** Smiths Medical received FDA clearance for its Jelco Hypodermic Needle-Pro Edge Safety Device, a new safety-engineered peripheral IV catheter designed to minimize needlestick injuries among healthcare workers. - **Q1 2024: Teleflex Receives CE Mark for Arrow® VPS Rhythm® DLX Device** Teleflex Incorporated announced it has received CE Mark approval for its Arrow® VPS Rhythm® DLX Device, which assists in the placement of peripheral intravenous catheters, expanding its European market presence. - **Q2 2024: Vygon Group Acquires Medcaptain Peripheral IV Catheter Business** Vygon Group completed the acquisition of Medcaptain's peripheral IV catheter business, strengthening its vascular access product portfolio and expanding its global reach in the intravenous therapy market. - **Q3 2024: Nipro Medical Corporation Opens New Manufacturing Facility in Georgia** Nipro Medical Corporation inaugurated a new manufacturing facility in Georgia, USA, dedicated to the production of peripheral intravenous catheters to meet growing demand in North America. - **Q1 2024: Becton Dickinson appoints new president for Medication Delivery Solutions** Becton Dickinson (BD) announced the appointment of a new president for its Medication Delivery Solutions segment, which includes the company's peripheral intravenous catheter business. - **Q2 2024: Vascular Pathways Announces Series B Funding to Advance PIVC Technology** Vascular Pathways closed a Series B funding round to accelerate the development and commercialization of its next-generation peripheral intravenous catheter technology. - **Q2 2024: ICU Medical Launches NutriCath™ Peripheral IV Catheter for Neonatal Care** ICU Medical introduced the NutriCath™ Peripheral IV Catheter, specifically designed for neonatal and pediatric patients, expanding its product offerings in the pediatric vascular access market. - **Q3 2024: Smiths Medical Partners with Medline for U.S. Distribution of Peripheral IV Catheters** Smiths Medical entered into a partnership with Medline Industries for the exclusive U.S. distribution of its peripheral intravenous catheter products, aiming to enhance market penetration. - **Q1 2025: B. Braun Receives FDA Clearance for Next-Generation Peripheral IV Catheter** B. Braun Medical Inc. received FDA clearance for its next-generation peripheral IV catheter, featuring advanced safety and infection prevention technologies. - **Q2 2025: Teleflex Expands Manufacturing Capacity for Peripheral IV Catheters in Malaysia** Teleflex announced the expansion of its manufacturing facility in Malaysia to increase production capacity for peripheral intravenous catheters, supporting global demand. - **Q2 2025: Smiths Medical appoints new CEO to drive growth in vascular access business** Smiths Medical named a new CEO, with a strategic focus on expanding its vascular access and peripheral intravenous catheter business. ## **Peripheral Intravenous Catheter Market Segmentation Insights** ### **Peripheral Intravenous Catheter Market Product Type Outlook** - Standard Peripheral Intravenous Catheters - Safety Peripheral Intravenous Catheters - Implantable Peripheral Intravenous Catheters ### **Peripheral Intravenous Catheter Market Material Outlook** - Polyurethane - Teflon - Polyethylene ### **Peripheral Intravenous Catheter Market Application Outlook** - Intravenous Therapy - Blood Transfusion - Drug Administration ### **Peripheral Intravenous Catheter Market Needle Gauge Outlook** - 16G - 18G - 20G ### **Peripheral Intravenous Catheter Market End User Outlook** - Hospitals - Clinics - Ambulatory Surgical Centers ### **Peripheral Intravenous Catheter Market Regional Outlook** - North America - Europe - South America - Asia Pacific - Middle East and Africa ## Market Drivers ### 医疗基础设施的扩展 医疗基础设施的扩展是外周静脉导管市场的重要驱动因素。随着各国投资于改善其医疗系统，先进医疗技术的可用性，包括外周静脉导管，正在增加。这一扩展在新兴市场中尤为明显，医疗设施正在升级以满足日益增长的患者需求。增强的基础设施促进了对静脉治疗的更好获取，从而推动了对高质量导管的需求。随着医疗系统的发展，外周静脉导管市场正处于增长的有利位置，反映了医疗发展中的更广泛趋势。 ### 慢性疾病发病率上升 外周静脉导管市场正在增长，原因是慢性疾病（如糖尿病、癌症和心血管疾病）的患病率不断上升。这些疾病通常需要长期的静脉治疗，从而推动了对外周静脉导管的需求。根据最近的统计数据，慢性疾病占医疗支出的很大一部分，这就需要高效可靠的静脉通道。随着医疗系统适应管理这些疾病，对先进导管技术的需求变得至关重要。这一趋势表明，外周静脉导管市场将继续扩展，因为医疗提供者寻求通过有效的治疗选项改善患者的治疗效果。 ### 导管设计中的技术创新 导管设计的创新正在推动外周静脉导管市场的发展。制造商越来越专注于开发能够提高患者舒适度并减少并发症的导管。例如，材料和涂层的进步使得导管能够降低血栓和感染的风险。配备实时监测传感器的智能导管的推出也正在获得关注。这些技术进步不仅提高了静脉治疗的有效性，还与日益重视患者安全和满意度的趋势相一致。因此，外周静脉导管市场可能会见证对这些创新产品的需求激增。 ### 对家庭医疗服务需求的增加 向家庭医疗服务的转变正在显著影响外周静脉导管市场。随着患者越来越倾向于在家中舒适地接受护理，对便携式和易于使用的静脉解决方案的需求也在上升。这一趋势在老年患者和那些需要持续治疗的慢性病患者中尤为明显。家庭医疗的便利性促使医疗服务提供者采用外周静脉导管，以便在家中进行治疗。因此，预计这一转变将推动外周静脉导管市场的发展，因为越来越多的患者寻求有效的家庭治疗选择。 ### 对感染控制措施的日益关注 外周静脉导管市场受益于对感染控制措施的高度关注。医疗机构越来越多地实施严格的协议，以最小化导管相关感染的风险。这种意识导致了先进导管技术的采用，旨在降低感染率，例如抗菌涂层导管。对感染预防的重视不仅提高了患者安全性，还降低了与治疗并发症相关的医疗成本。随着医疗提供者优先考虑感染控制，外周静脉导管市场可能会看到与这些做法相一致的产品需求上升。 ## Future Outlook 外周静脉导管市场预计将在2024年至2035年间以5.59%的年均增长率增长，推动因素包括技术进步、医疗需求增加和慢性疾病上升。 **New opportunities:** - 开发集成监测系统的智能静脉导管。 到2035年，市场预计将实现显著增长，反映出不断变化的医疗保健需求。 ## Segment Insights ### 按类型：标准外周静脉导管（最大）与安全外周静脉导管（增长最快） 在外周静脉导管市场中，标准外周静脉导管占据了最大的市场份额，主要是由于它们在医院和诊所中被广泛采用用于常规静脉治疗。相比之下，安全外周静脉导管旨在增强安全性并减少针刺伤的风险，正在获得关注，并且是增长最快的细分市场，反映出对患者和医疗工作者安全性的日益重视。 标准外周静脉导管（主流）与安全外周静脉导管（新兴） 标准外周静脉导管因其可靠性和医疗服务提供者对其在各种医疗程序中的信任而主导市场。它们通常更具成本效益，使其成为一般应用的首选。另一方面，安全外周静脉导管代表了一种新兴趋势，专注于减少与传统导管相关的风险。它们结合了安全特性，显著降低了医疗专业人员的受伤率，因此吸引了旨在提高工作场所安全性并遵守严格法规的机构。 ### 按材料：聚氨酯（最大）与特氟龙（增长最快） 在外周静脉导管市场中，材料细分展示了一个竞争激烈的格局，以聚氨酯为主导，因其灵活性和耐用性而获得最大的市场份额。聚乙烯和特氟龙虽然也很突出，但由于特定应用和患者需求而逐渐受到关注。这两种材料满足了对特定医疗程序和病症日益增长的需求，为市场提供了多样化的产品。 聚氨酯（主导）与特氟龙（新兴） 聚氨酯仍然是外周静脉导管市场的主导材料，主要由于其优越的生物相容性和抗扭曲性，这增强了患者在长期使用过程中的舒适度。相比之下，特氟龙作为一个重要参与者正在崛起，以其光滑的表面而闻名，能够减少摩擦并提高插入的便利性。随着医疗服务提供者专注于减少并发症，如静脉炎和渗漏，特氟龙的独特特性预计将在未来几年推动其增长。市场的演变以材料的持续进步为特征，导致两个细分市场的采用率不断提高。 ### 按应用：静脉治疗（最大）与输血（增长最快） 外周静脉导管市场的应用领域主要由静脉治疗驱动，该领域在整体市场中占有重要份额。这种方法在临床环境中被广泛使用，因为它能够有效地将液体、药物和营养物质直接输送到血液中，从而提高患者的康复率。相比之下，输血正成为增长最快的细分市场，这得益于手术程序、创伤病例的增加以及慢性疾病患者对血液产品需求的上升。这一转变表明市场格局正在多样化，关注各种患者需求。 应用：静脉治疗（主导）与输血（新兴） 静脉治疗是外周静脉导管市场的主要应用，其在医院护理和门诊治疗中发挥着至关重要的作用。这种方法确保了药物和液体的快速给药，使其在紧急情况和常规治疗中不可或缺。同时，输血作为一种重要应用，逐渐获得关注，得益于输血技术的进步以及贫血和手术需求等情况的日益普遍。输血的增长驱动因素包括改善的患者管理策略和增强的输血安全措施，使其成为该领域制造商关注的重点。 ### 按针头规格：18G（最大）与20G（增长最快） 在外周静脉导管市场中，针头规格细分展示了各个规格之间市场份额的多样分布。18G针头规格因其多功能性和在临床环境中的广泛使用而占据市场的最大份额。相比之下，20G细分市场正在崛起，成为一个重要的参与者，这得益于其与各种患者人群的兼容性，以及对患者的使用便利性和减少创伤。 针头规格细分市场的增长趋势受到住院率和需要外周静脉通路的程序增加的显著影响。导管技术的进步、对患者舒适度的日益关注以及政府法规促进更安全医疗实践等因素，均为20G细分市场的积极增长轨迹做出了贡献。随着医疗机构专注于建立以患者为中心的方法，预计未来几年对20G导管的需求将急剧加速。 18G（主导）与16G（新兴） 在针头规格类别中，18G规格因其在液体输送能力和患者舒适度之间的平衡而脱颖而出，成为主导力量。该规格主要用于各种医疗程序，因其较大的腔径而促进高效的输血和输液。相对而言，16G规格虽然使用较少，但在需要快速液体输送的特定应用中逐渐受到认可。其较大的口径允许相当的液体流动，使其在紧急情况下具有优势。这些规格的市场定位反映了它们在不同医疗背景下的实用性，符合不断发展的医疗需求和优先考虑疗效与患者安全的创新。 ### 按最终用户：医院（最大）与诊所（增长最快） 在外周静脉导管市场中，医院作为最大的终端用户细分市场，占据了市场活动的显著部分。它们广泛的基础设施和关键护理需求推动了对外周静脉导管的需求，使其成为整体市场动态的核心。尽管诊所的市场份额相较于医院较小，但随着它们越来越多地采用先进的导管技术用于门诊护理和小型手术，利用率正在迅速上升。 医院（主导）与诊所（新兴） 医院在外周静脉导管市场中发挥着主导作用，因为它们的患者数量较多，并且需要复杂的医疗解决方案。这些设施不仅将这些导管用于广泛的应用，包括手术和急救护理，而且还投资于培训和技术，以确保最佳的患者结果。另一方面，诊所作为重要参与者正在崛起，这得益于对微创手术和门诊服务日益增长的偏好。它们对外周静脉导管的采用得到了技术进步的支持，这些进步使得操作更为简便，患者舒适度更高，反映出向分散式医疗服务的转变。 ## Regional Market Share Analysis ### 北美：创新的市场领导者 北美是外周静脉导管最大的市场，约占全球市场份额的45%。该地区的增长受到先进医疗基础设施、慢性疾病患病率上升以及手术数量增加的推动。来自FDA等机构的监管支持进一步促进了市场扩展，确保医疗设备的安全性和有效性。美国是主要贡献者，主要参与者包括贝克顿·迪金森公司、史密斯医疗和嘉德医疗，主导着竞争格局。成熟的医疗设施和对创新导管技术的关注增强了市场动态。加拿大也发挥着重要作用，凭借其强大的医疗系统和对优质医疗设备日益增长的需求，促进了整体增长。 ### 欧洲：具有增长潜力的新兴市场 欧洲在外周静脉导管市场上正经历显著增长，约占全球市场份额的30%。老龄化人口、医疗支出增加以及医疗技术进步等因素推动了需求。包括医疗器械法规（MDR）在内的监管框架确保了产品安全性和有效性的高标准，进一步增强了市场信心。该地区的主要国家包括德国、法国和英国，主要参与者如费森尤斯·卡比公司和维戈公司在其中占据重要地位。竞争格局由一系列成熟公司和创新初创企业组成，专注于开发先进的导管技术。该地区对改善患者护理和减少医院获得性感染的重视预计将进一步推动市场增长。 ### 亚太地区：快速增长的医疗保健部门 亚太地区正在成为外周静脉导管市场的重要参与者，约占全球市场份额的20%。该地区的增长受到医疗投资增加、人口上升和慢性疾病患病率上升的推动。中国和印度等国正在经历医疗基础设施的快速进步，这对市场扩展至关重要。监管机构也变得更加严格，以确保医疗设备的质量。中国是该地区最大的市场，其次是印度和日本。竞争格局中既有本地企业也有国际企业，包括泰尔茂公司和尼普罗公司。对经济实惠的医疗解决方案的关注以及医院和诊所数量的增加正在推动对外周静脉导管的需求，使该地区成为未来增长的关键领域。 ### 中东和非洲：未开发的市场机会 中东和非洲地区在外周静脉导管市场上逐渐崭露头角，目前约占全球市场份额的5%。增长受到医疗投资增加、对先进医疗技术的认识提高以及患者人口增长的推动。各国政府正专注于改善医疗基础设施，这对市场发展至关重要。监管机构也开始实施更严格的指导方针，以确保产品的安全性和有效性。南非和阿联酋等国在市场中处于领先地位，医疗设施数量不断增加，对优质医疗设备的需求也在上升。竞争格局由本地和国际参与者混合构成，在城市和农村医疗环境中都有增长机会。该地区对提高医疗可及性和质量的关注预计将在未来几年推动对外周静脉导管的需求。 ## Competitive Benchmarking 外周静脉导管市场目前的特点是动态的竞争格局，受到日益增长的医疗需求和技术进步的推动。主要参与者如贝克顿·迪金森公司（美国）、Terumo公司（日本）和美敦力公司（爱尔兰）战略性地定位以利用创新并扩大其市场存在。贝克顿·迪金森公司（美国）专注于通过持续的研究和开发来提高产品的安全性和有效性，而Terumo公司（日本）则强调区域扩张和合作伙伴关系，以加强其分销网络。美敦力公司（爱尔兰）积极追求数字化转型举措，将先进技术整合到其产品中，这共同塑造了一个优先考虑创新和对市场需求响应的竞争环境。 在商业策略方面，公司越来越多地本地化制造，以降低成本并提高供应链效率。市场结构似乎适度分散，几家主要参与者在各个细分市场中施加影响。这种分散性使得小型参与者能够蓬勃发展，而大型公司则通过战略收购和合作伙伴关系巩固其地位，从而增强其竞争优势。 在2025年8月，贝克顿·迪金森公司（美国）宣布推出一系列新的安全工程IV导管，旨在最小化针刺伤害的风险。这一战略举措不仅解决了医疗专业人员日益增长的安全担忧，还将公司定位为市场创新的领导者。这些产品的推出可能会增强贝克顿·迪金森的市场份额，并强化其对患者安全的承诺。 在2025年9月，Terumo公司（日本）与一家领先的远程医疗提供商达成合作伙伴关系，将远程监测能力整合到其IV导管系统中。这一合作标志着向数字健康解决方案的转变，允许实时患者数据收集和改善临床结果。这种战略联盟可能通过将其产品与医疗提供者不断变化的需求对齐来增强Terumo的竞争地位。 在2025年10月，美敦力公司（爱尔兰）推出了一种新的基于人工智能的分析平台，旨在优化IV导管的放置和管理。这种创新方法不仅简化了临床工作流程，还通过减少与导管使用相关的并发症来改善患者护理。美敦力专注于将人工智能整合到其产品中，反映了行业内利用技术改善医疗服务的更广泛趋势。 截至2025年10月，外周静脉导管市场的竞争趋势越来越多地由数字化、可持续性和人工智能的整合所定义。战略联盟在塑造市场格局中变得至关重要，因为公司寻求增强其技术能力和市场覆盖。展望未来，竞争差异化可能会从传统的基于价格的竞争演变为关注创新、技术进步和供应链可靠性，强调在快速变化的市场中适应能力的重要性。 ## Recent News & Developments - **2024年第二季度：B. Braun在美国推出Introcan Safety® 2静脉导管** B. Braun Medical Inc.宣布在美国推出Introcan Safety® 2静脉导管，旨在减少针刺伤害并提高患者安全性，扩展其外周静脉导管产品组合。 - **2024年第二季度：Smiths Medical宣布Jelco皮下注射针-Pro Edge安全装置获得FDA批准** Smiths Medical获得FDA批准，推出其Jelco皮下注射针-Pro Edge安全装置，这是一种新型安全设计的外周静脉导管，旨在减少医疗工作者的针刺伤害。 - **2024年第一季度：Teleflex获得Arrow® VPS Rhythm® DLX设备的CE标志** Teleflex Incorporated宣布已获得Arrow® VPS Rhythm® DLX设备的CE标志，该设备协助放置外周静脉导管，扩展其在欧洲市场的影响力。 - **2024年第二季度：Vygon集团收购Medcaptain外周静脉导管业务** Vygon集团完成对Medcaptain外周静脉导管业务的收购，增强其血管通路产品组合，扩大其在静脉治疗市场的全球影响力。 - **2024年第三季度：Nipro Medical Corporation在乔治亚州开设新制造设施** Nipro Medical Corporation在美国乔治亚州揭幕一座新的制造设施，专注于生产外周静脉导管，以满足北美日益增长的需求。 - **2024年第一季度：Becton Dickinson任命新总裁负责药物输送解决方案** Becton Dickinson (BD)宣布任命一位新总裁，负责其药物输送解决方案部门，该部门包括公司的外周静脉导管业务。 - **2024年第二季度：Vascular Pathways宣布进行B轮融资以推进PIVC技术** Vascular Pathways完成了一轮B轮融资，以加速其下一代外周静脉导管技术的开发和商业化。 - **2024年第二季度：ICU Medical推出NutriCath™外周静脉导管用于新生儿护理** ICU Medical推出NutriCath™外周静脉导管，专为新生儿和儿童患者设计，扩展其在儿童血管通路市场的产品供应。 - **2024年第三季度：Smiths Medical与Medline合作在美国分销外周静脉导管** Smiths Medical与Medline Industries达成合作，独家在美国分销其外周静脉导管产品，旨在增强市场渗透率。 - **2025年第一季度：B. Braun获得下一代外周静脉导管的FDA批准** B. Braun Medical Inc.获得其下一代外周静脉导管的FDA批准，该导管具有先进的安全性和感染预防技术。 - **2025年第二季度：Teleflex在马来西亚扩大外周静脉导管的生产能力** Teleflex宣布扩大其在马来西亚的制造设施，以增加外周静脉导管的生产能力，以支持全球需求。 - **2025年第二季度：Smiths Medical任命新首席执行官以推动血管通路业务增长** Smiths Medical任命新首席执行官，战略重点是扩展其血管通路和外周静脉导管业务。 ## Report Scope | 2024年市场规模 | 96.2（十亿美元） | | --- | --- | | 2025年市场规模 | 101.6（十亿美元） | | 2035年市场规模 | 175（十亿美元） | | 复合年增长率（CAGR） | 5.59%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 关键公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 关键市场机会 | 智能技术在外周静脉导管市场的整合增强了患者安全性和监测能力。 | | 关键市场动态 | 技术进步和监管变化推动外周静脉导管市场的创新和竞争。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 到2035年，外周静脉导管市场的预计市场估值是多少？** A: 外周静脉导管市场预计到2035年将达到175亿美元的估值。 **Q: 2024年外周静脉导管市场的市场估值是多少？** A: 在2024年，外周静脉导管市场的市场估值为96.2亿美元。 **Q: 在2025年至2035年的预测期内，外周静脉导管市场的预期CAGR是多少？** A: 在2025年至2035年的预测期内，外周静脉导管市场的预期年复合增长率（CAGR）为5.59%。 **Q: 在外周静脉导管市场中，哪些公司被视为关键参与者？** A: 市场上的主要参与者包括贝克顿·迪金森公司、史密斯医疗、泰尔茂公司和美敦力公司。 **Q: 到2035年，标准外周静脉导管的预计收入是多少？** A: 预计到2035年，标准外周静脉导管的预期收入将达到68.8亿美元。 **Q: 安全外周静脉导管在市场估值方面表现如何？** A: 安全外周静脉导管预计到2035年将实现57.5亿美元的市场估值。 **Q: 到2035年，植入式外周静脉导管的预期市场规模是多少？** A: 预计到2035年，植入式外周静脉导管的市场规模将达到48.7亿美元。 **Q: 到2035年，预计哪个材料细分市场将主导外周静脉导管市场？** A: 聚氨酯材料细分市场预计将主导市场，到2035年达到69.3亿美元。 **Q: 到2035年，静脉治疗应用的预期市场规模是多少？** A: 预计到2035年，静脉治疗应用的市场规模将达到70.4亿美元。 **Q: 到2035年，医院的最终用户细分与诊所相比如何？** A: 到2035年，医院的市场规模预计将达到80亿美元，远高于预计的诊所45亿美元。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/peripheral-intravenous-catheter-market-30180*